2,1,3-Benzothiadiazoles as myolonolytics
AssigneeSandoz Ltd.
InventorsErwin Eichenberger, Peter Neumann
Life of this patent
Estimating the term…
Abstract
This invention provides a new myotonolytic use of 2,1,3-benzothiadiazole derivatives and novel pharmaceutical compositions for such use.
Claims16
A method of treating spastic conditions which comprises administering to an animal in need of such treatment a therapeutically effective amount of a compound of the formula ##STR2## wherein each of R.sub.1, R.sub.2 and R.sub.3 independently, is hydrogen, halogen, alkyl, alkoxy, nitro, cyano, hydroxy or alkylthio,
- or a pharmaceutically acceptable acid addition salt form thereof.
A method of relaxing muscles which comprises administering to an animal in need of such treatment a muscle-relaxing amount of a compound of the formula ##STR3## wherein each of R.sub.1, R.sub.2 and R.sub.3 independently, is hydrogen, halogen, alkyl, alkoxy, nitro, cyano, hydroxy or alkylthio,
- or a pharmaceutically acceptable acid addition salt form thereof.
Dependencies are inferred from the claim text.